J Med Microbiol Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujita, Y.
Right arrow Articles by Yano, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujita, Y.
Right arrow Articles by Yano, I.
Agricola
Right arrow Articles by Fujita, Y.
Right arrow Articles by Yano, I.
J Med Microbiol 55 (2006), 189-199; DOI: 10.1099/jmm.0.46087-0
© 2006 Society for General Microbiology
ISSN 0022-2615

Differences in serological responses to specific glycopeptidolipid-core and common lipid antigens in patients with pulmonary disease due to Mycobacterium tuberculosis and Mycobacterium avium complex

Yukiko Fujita1, Takeshi Doi1, Ryoji Maekura2, Masami Ito2 and Ikuya Yano1

1 Japan BCG Central Laboratory, 3-1-5 Matsuyama, Kiyose-shi, Tokyo 204-0022, Japan

2 Toneyama National Hospital, 5-1-1 Toneyama, Toyonaka-shi, Osaka 560-0045, Japan

Correspondence
Yukiko Fujita
y-fujita{at}bcg.gr.jp

Received 14 March 2005
Accepted 15 October 2005

Disease due to the Mycobacterium avium complex (MAC) is one of the most important opportunistic pulmonary infections. Since the clinical features of MAC pulmonary disease and tuberculosis (TB) resemble each other, and the former is often difficult to treat with chemotherapy, early differential diagnosis is desirable. The humoral immune responses to both diseases were compared by a unique multiple-antigen ELISA using mycobacterial species-common and species-specific lipid antigens, including glycopeptidolipid (GPL)-core. The results were assessed for two patient groups hospitalized and diagnosed clinically as having TB or MAC pulmonary disease. Diverse IgG antibody responsiveness was demonstrated against five lipid antigens: (1) monoacyl phosphatidylinositol dimannoside (Ac-PIM2), (2) cord factor (trehalose 6,6'-dimycolate) (TDM-T) and (3) trehalose monomycolate from Mycobacterium bovis Bacillus Calmette-Guérin (BCG) (TMM-T), and (4) trehalose monomycolate (TMM-M) and (5) GPL-core from MAC. Anti-GPL-core IgG antibody was critical, and detected only in the primary and the secondary MAC diseases with high positivity, up to 88·4 %. However, IgG antibodies against Ac-PIM2, TDM-T and TMM-T were elevated in both TB and MAC patients. Anti-TMM-M IgG antibody was also elevated in MAC disease preferentially, with a positive rate of 89·9 %, and therefore, it was also useful for the diagnosis of the disease. IgG antibody levels were increased at the early stages of the disease and declined in parallel to the decrease of bacterial burden to near the normal healthy control level, when the anti-mycobacterial chemotherapy was completed successfully. Unexpectedly, about 25 % of hospitalized TB patient sera were anti-GPL-core IgG antibody positive, although the specificity of GPL-core was sufficiently high (95·8 % negative in healthy controls), suggesting that a considerable number of cases of latent co-infection with MAC may exist in TB patients. Taken together, the combination of multiple-antigen ELISA using mycobacterial lipids, including GPL-core and TMM-M, gives good discrimination between healthy controls and sera from patients with TB or MAC disease, although for accurate diagnosis of TB more specific antigen(s) are needed.

Abbreviations: Ac-PIM2, monoacyl phosphatidylinositol dimannoside; BCG, Bacillus Calmette-Guérin; GPL, glycopeptidolipid; MAC, Mycobacterium avium complex; TB, tuberculosis; TDM, trehalose 6,6'-dimycolate; TMM, trehalose monomycolate.




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Kitada, K. Kobayashi, S. Ichiyama, S. Takakura, M. Sakatani, K. Suzuki, T. Takashima, T. Nagai, I. Sakurabayashi, M. Ito, et al.
Serodiagnosis of Mycobacterium avium-Complex Pulmonary Disease Using an Enzyme Immunoassay Kit
Am. J. Respir. Crit. Care Med., April 1, 2008; 177(7): 793 - 797.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
N. Fujiwara, N. Nakata, S. Maeda, T. Naka, M. Doe, I. Yano, and K. Kobayashi
Structural Characterization of a Specific Glycopeptidolipid Containing a Novel N-Acyl-Deoxy Sugar from Mycobacterium intracellulare Serotype 7 and Genetic Analysis of Its Glycosylation Pathway
J. Bacteriol., February 1, 2007; 189(3): 1099 - 1108.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2006 Society for General Microbiology.